Abstract
Two categories of tests are performed: (i) product quality tests and (ii) product performance tests. Product quality tests are intended to assess attributes of the dosage form whereas product performance tests are designed to assess the performance of the dosage form that in many cases is related to the drug release from the dosage form. Quality and performance tests together assure identity, strength, quality, purity, and performance of the drug product. All quality and performance tests for topical dosage forms are described.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Pharmacopeial Forum: 32(5) Sept–Oct 2006, 1586–9.
USP General Chapters <3>; <1724> and <724.>
FDA draft guidance on acyclovir ointment 0.05 %, March 2012.
FDA draft guidance on cyclosporine emulsions/ophthalmic, June 2013.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Yacobi, A., Ueda, C., Shah, V. (2014). In Vitro Product Quality Tests and Product Performance Tests for Topical and Transdermal Drug Products. In: Shah, V., Maibach, H., Jenner, J. (eds) Topical Drug Bioavailability, Bioequivalence, and Penetration. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-1289-6_6
Download citation
DOI: https://doi.org/10.1007/978-1-4939-1289-6_6
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-1288-9
Online ISBN: 978-1-4939-1289-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)